Is the Blood-Brain Barrier Relevant in Metastatic Germ Cell Tumor?

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: Germ cell tumors are uniquely chemosensitive and curable, even with advanced metastatic disease. Central nervous system recurrence can terminate a complete remission in other chemosensitive tumors, such as small cell lung cancer, because of the blood-brain barrier (BBB). We propose to document that the BBB is also relevant in germ cell tumors despite their dramatic chemosensitivity. Methods and Materials: We present five cases illustrating the concept of the BBB in patients with metastatic testicular cancer treated with chemotherapy. Results: In our large series of patients with metastatic testicular cancer treated with chemotherapy, we identified 5 unique patients. These patients were rendered free of disease only to experience relapse in the brain alone. This included 1 patient who initially had good-risk metastatic disease by means of the International Germ Cell Collaborative Group staging system at the onset of chemotherapy. Conclusions: The BBB is relevant in patients with metastatic testicular cancer.

Original languageEnglish
Pages (from-to)163-166
Number of pages4
JournalInternational Journal of Radiation Oncology Biology Physics
Volume69
Issue number1
DOIs
StatePublished - Sep 1 2007

Fingerprint

blood-brain barrier
Germ Cell and Embryonal Neoplasms
Blood-Brain Barrier
tumors
Testicular Neoplasms
chemotherapy
cancer
Drug Therapy
Recurrence
central nervous system
Small Cell Lung Carcinoma
Germ Cells
lungs
brain
Central Nervous System
Brain
Neoplasms

Keywords

  • Blood-brain barrier
  • Brain metastasis
  • Germ cell tumor
  • Testicular cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

@article{c768375a70e34a52970240d6ac30c62a,
title = "Is the Blood-Brain Barrier Relevant in Metastatic Germ Cell Tumor?",
abstract = "Purpose: Germ cell tumors are uniquely chemosensitive and curable, even with advanced metastatic disease. Central nervous system recurrence can terminate a complete remission in other chemosensitive tumors, such as small cell lung cancer, because of the blood-brain barrier (BBB). We propose to document that the BBB is also relevant in germ cell tumors despite their dramatic chemosensitivity. Methods and Materials: We present five cases illustrating the concept of the BBB in patients with metastatic testicular cancer treated with chemotherapy. Results: In our large series of patients with metastatic testicular cancer treated with chemotherapy, we identified 5 unique patients. These patients were rendered free of disease only to experience relapse in the brain alone. This included 1 patient who initially had good-risk metastatic disease by means of the International Germ Cell Collaborative Group staging system at the onset of chemotherapy. Conclusions: The BBB is relevant in patients with metastatic testicular cancer.",
keywords = "Blood-brain barrier, Brain metastasis, Germ cell tumor, Testicular cancer",
author = "Jose Azar and Bryan Schneider and Lawrence Einhorn",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.ijrobp.2007.02.042",
language = "English",
volume = "69",
pages = "163--166",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Is the Blood-Brain Barrier Relevant in Metastatic Germ Cell Tumor?

AU - Azar, Jose

AU - Schneider, Bryan

AU - Einhorn, Lawrence

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Purpose: Germ cell tumors are uniquely chemosensitive and curable, even with advanced metastatic disease. Central nervous system recurrence can terminate a complete remission in other chemosensitive tumors, such as small cell lung cancer, because of the blood-brain barrier (BBB). We propose to document that the BBB is also relevant in germ cell tumors despite their dramatic chemosensitivity. Methods and Materials: We present five cases illustrating the concept of the BBB in patients with metastatic testicular cancer treated with chemotherapy. Results: In our large series of patients with metastatic testicular cancer treated with chemotherapy, we identified 5 unique patients. These patients were rendered free of disease only to experience relapse in the brain alone. This included 1 patient who initially had good-risk metastatic disease by means of the International Germ Cell Collaborative Group staging system at the onset of chemotherapy. Conclusions: The BBB is relevant in patients with metastatic testicular cancer.

AB - Purpose: Germ cell tumors are uniquely chemosensitive and curable, even with advanced metastatic disease. Central nervous system recurrence can terminate a complete remission in other chemosensitive tumors, such as small cell lung cancer, because of the blood-brain barrier (BBB). We propose to document that the BBB is also relevant in germ cell tumors despite their dramatic chemosensitivity. Methods and Materials: We present five cases illustrating the concept of the BBB in patients with metastatic testicular cancer treated with chemotherapy. Results: In our large series of patients with metastatic testicular cancer treated with chemotherapy, we identified 5 unique patients. These patients were rendered free of disease only to experience relapse in the brain alone. This included 1 patient who initially had good-risk metastatic disease by means of the International Germ Cell Collaborative Group staging system at the onset of chemotherapy. Conclusions: The BBB is relevant in patients with metastatic testicular cancer.

KW - Blood-brain barrier

KW - Brain metastasis

KW - Germ cell tumor

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=34547838168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547838168&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2007.02.042

DO - 10.1016/j.ijrobp.2007.02.042

M3 - Article

C2 - 17707269

AN - SCOPUS:34547838168

VL - 69

SP - 163

EP - 166

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 1

ER -